Rafael Rosell

发表论文 234 篇 · 总被引 25023 次 · h-index 55

代表论文

• Impact of Specific Epidermal Growth Factor Receptor ( EGFR ) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR -Mutant Lung Cancer: A Meta-Analysis (2015 · Journal of Clinical Oncology · 被引 330)
• Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial (2015 · JAMA Oncology · 被引 240)
• The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial (2014 · Clinical Cancer Research · 被引 230)
• Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer (2018 · Journal of Thoracic Oncology · 被引 191)
• Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial (2017 · The Lancet Respiratory Medicine · 被引 184)
• A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) (2015 · Annals of Oncology · 被引 110)